GHK-Cu — Scalp & Follicle Biology
GHK-Cu is a copper-binding peptide associated with tissue-remodeling pathways.
Intended role: Included as a complementary ingredient focused on scalp and follicle biology.
Hair · topical
GHK-Cu 5 mg/mL + Finasteride 0.1% · 30 mL
Source-catalog strengths and quantity shown. Current dispensing label and clinical approval remain pending.
A topical hair formulation combining finasteride, which acts on a hormonal pathway associated with pattern hair loss, with GHK-Cu, a copper peptide explored for its effects on skin and follicle-related tissue biology.
This formula combines finasteride with a copper peptide. It requires medical screening and prescribing review; it is not presented as an ordinary cosmetic.
Improve Hair
GHK-Cu 5 mg/mL + Finasteride 0.1% · 30 mL
Source-catalog strengths and quantity shown. Current dispensing label and clinical approval remain pending.
GHK-Cu is a copper-binding peptide associated with tissue-remodeling pathways.
Intended role: Included as a complementary ingredient focused on scalp and follicle biology.
Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT). DHT contributes to the progressive miniaturization of susceptible hair follicles in androgenetic hair loss.
Intended role: Provides the DHT-reduction mechanism within the formulation.
Product education reviewed by Dr. Rouzbeh Sattari — owner-reported verbal approval, October 8, 2026. Current pharmacy labeling and individual clinical approval must be confirmed before treatment. Ingredient names do not establish a dose, route or treatment recommendation.
Evidence, safety & treatment information ↗Share your goals, medical history and medications securely.
A licensed clinician reviews suitability, risks and alternatives.
If appropriate and available, an authorized order is reviewed manually. Direct pharmacy fulfillment can be connected after confirmation.
Ongoing clinical review guides monitoring and refill decisions.
Intended goals and biological mechanisms do not establish clinical outcomes for this formulation. Individual response varies; benefits are not guaranteed.
Topical finasteride is not FDA-approved. Systemic absorption and adverse effects are possible. A clinician must discuss reproductive risks, handling and suitability before treatment.
Treatment requires individual medical evaluation and a prescription where applicable. It depends on clinician judgment, eligibility, and verified pharmacy and state availability. A program selection does not guarantee treatment.
Compounded medications are not FDA-approved; FDA does not review them for safety, effectiveness or quality before marketing. Approval or evidence for one ingredient or branded medicine does not establish the same for this formulation. Outcomes vary and are not guaranteed.
Discuss adverse effects, interactions, pregnancy or reproductive considerations and appropriate alternatives with your clinician. Formulation, route, dosing and monitoring must be confirmed before treatment.
Read the full medical & treatment information ↗No payment is taken in this website.
See the topical product inclusions above. Each subsequent treatment order is purchased separately; there is no automatic renewal.